|Day Low/High||21.82 / 22.54|
|52 Wk Low/High||15.67 / 24.79|
Before Wednesday's market open Boston Scientific (BSX) will post 2016 third quarter results.
Launch of Hemostasis Clip Advances Innovation within the Field of Endoscopy
Acquisition Will Expand Endoscopy Gastroenterology Portfolio
Cramer will be monitoring earnings and the Federal Reserve next week.
Demand is quite healthy and markets are not going into the abyss, Cramer says.
Pay attention to what companies are doing to improve themselves, not the hand-wringing from fund managers about Fed intervention.
Wells Fargo CEO John Stumpf apologizes to the bank's customers and Cramer says Boston Scientific is a stock to buy right now.
But Cramer continues to raise cash for his charitable trust so he can pounce on quality stocks as the market takes them lower.
In the last year, shares of Boston Scientific are up almost 50%. Boston Scientific is putting the problems of the past behind it and has a bright future.
Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.
These stocks have both short-term gain catalysts and longer-term growth potential.
Approval Grants MR-Conditional Labeling to All EMBLEM S-ICD Systems, Expands ImageReady™ Portfolio
Stocks with insider trader activity include SXC, BSX and KFS
Jefferies upped its price target to $24 on Boston Scientific (BSX) stock this morning.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BCC, CYS, DISH, ESRT, FCFS, FSI, GIMO, INVA, KSU, NATI, ORC, RMCF, TREE, WLDN, WMGI, WRE, ZION Downgrades: ACIW, ACOR, BSX, DLR, FI, HTH, IP, OVBC, SBBX Initiations: GNRT, MB, PUB Read on to get TheStreet Quant Ratings' detailed report:
Boston Scientific (BSX) stock is advancing this morning after the company posted better-than-expected fiscal 2016 second quarter revenue before today's opening bell.
Trade-Ideas LLC identified Boston Scientific (BSX) as an unusual social activity candidate
Trade-Ideas LLC identified Boston Scientific (BSX) as a post-market leader candidate
TheStreet highlights 3 stocks pushing the health care sector lower today.
Addition of Leading Radiofrequency Ablation Company Expands Therapeutic Options for Patients with Chronic Pain
TheStreet highlights 3 stocks pushing the health services industry lower today.
Can medical technology stocks continue their momentum higher in the second half of the year? Investors say yes, but technical analysis says not necessarily.
Listen to what the companies are actually telling you. Then assess what that might mean for the future, Cramer says.